Global Infertility Market 2015-2019

Global Infertility Market 2015-2019

Category : Pharmaceuticals
Published On : February  2015
Pages : 92



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

About Infertility
Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems.  

TechNavio's analysts forecast the Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Infertility market for the period 2015-2019. The Global Infertility market can be divided into two segments: Infertility Drugs and Infertility Devices. To calculate the market size, the report considers revenue generated from the sales of various drugs and devices used in the treatment of infertility.

TechNavio's report, the Global Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Infertility market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas 
• APAC
• EMEA        

Key Vendors
• Bayer Healthcare 
• CooperSurgical
• Ferring Pharmaceuticals
• Merck & Co.

Other Prominent Vendors
• Abbott Laboratories
• AbbVie
• Actavis
• Apricus Biosciences
• AstraZeneca
• Bristol-Myers Squibb
• Dong-A Socio
• Elelixis Diagnostics
• Eli Lily
• Halotech DNA
• HRA Pharma
• Invo Bioscience
• Medical Electronic Systems
• Novartis
• Pfizer
• PregLem
• Sanofi
• Vivus

Market Driver
• Increase in Aging Population
• For a full, detailed list, view our report

Market Challenge
• Patent Expires of Major Blockbuster Drugs
• For a full, detailed list, view our report

Market Trend
• Increase in Awareness
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Disease Overview

06.1 Etiology

06.1.1 Male Infertility Etiology

06.1.2 Pre-testicular

06.1.3 Testicular

06.1.4 Post-testicular

06.1.5 Others

06.1.6 Female Infertility Etiology

06.1.7 Female Infertility associated with Anovulation

06.1.8 Female Infertility of Tubal Origin

06.1.9 Female Infertility of Uterine Origin

06.1.10 Female Infertility of Other Origin

06.1.11 Female Infertility, Unspecified

06.2 Signs and Symptoms

06.2.1 Male Infertility Signs and Symptoms

06.2.2 Female Infertility Signs and Symptoms

06.3 Treatment

06.3.1 Treatment for Male Infertility

06.3.2 Treatment for Female Infertility

06.3.3 Reproductive Assistance

06.4 Tests and Diagnosis

06.4.1 Male: Tests and Diagnosis

06.4.2 Female: Tests and Diagnosis

06.4.3 Prevalence

07. Country Overview

07.1.1 US

07.1.2 UK

08. Market Landscape

08.1 Market Overview

08.2 Market Size and Forecast

08.3 Five Forces Analysis

09. Market Segmentation by Type

09.1.1 Infertility Drugs

09.1.2 Infertility Devices

09.2 Global Infertility Drugs Market

09.2.1 Market Size and Forecast

09.3 Global Infertility Devices Market

09.3.1 Market Size and Forecast

10. Market Segmentation by Underlying Cause

11. Geographical Segmentation

11.1 Infertility Market in Americas

11.1.1 Market Size and Forecast

11.2 Infertility Market in APAC Region

11.2.1 Market Size and Forecast

11.3 Infertility Market in EMEA Region

11.3.1 Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Licensing and Collaborations

19.1.3 Mergers and Acquisitions

19.2 Market Share Analysis 2014

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Bayer HealthCare

20.1.1 Key Facts

20.1.2 Business Overview

20.1.3 Business Segmentation by Revenue 2013

20.1.4 Business Segmentation by Revenue 2012 and 2013

20.1.5 Geographical Segmentation by Revenue 2013

20.1.6 Business Strategy

20.1.7 Recent Developments

20.1.8 SWOT Analysis

20.2 CooperSurgical

20.2.1 Key Facts

20.2.2 Business Description

20.2.3 Business Segmentation

20.2.4 Business Segmentation by Revenue

20.2.5 Business Segmentation by Revenue 2012 and 2013

20.2.6 Business Strategy

20.2.7 Key Developments

20.2.8 SWOT Analysis

20.3 Ferring Pharmaceuticals

20.3.1 Key Facts

20.3.2 Business Overview

20.3.3 SWOT Analysis

20.4 Merck & Co. Inc.

20.4.1 Key Facts

20.4.2 Business Overview

20.4.3 Business Segmentation by Revenue 2013

20.4.4 Business Segmentation by Revenue 2012 and 2013

20.4.5 Sales by Geography

20.4.6 Business Strategy

20.4.7 Key Developments

20.4.8 SWOT Analysis

21. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Etiology of Male Infertility

Exhibit 3: Etiology of Female Infertility

Exhibit 4: Treatment of Male Infertility

Exhibit 5: Diagnosis of Male Infertility

Exhibit 6: Factors Affecting Infertility in 2014 (Global)

Exhibit 7: Percentage of Primary and Secondary Infertility in 2010 (Global)

Exhibit 8: Percentage of Married Infertile Women with Primary Infertility: US, 1965–2010

Exhibit 9: Causes of Infertility in US

Exhibit 10: Increasing Prevalence of Infertility of Women (various age-groups in year) in UK 2009

Exhibit 11: Causes of Infertility in UK 2009

Exhibit 12: Global Infertility Market 2014-2019 (US$ million)

Exhibit 13: Segmentation of Global Infertility Market by Type

Exhibit 14: Global Infertility Drugs Market 2014-2019 (US$ million)

Exhibit 15: Global Infertility Devices Market 2014-2019 (US$ million)

Exhibit 16: Global infertility market by drugs & devices in 2014 and 2019 (US$ million)

Exhibit 17: Global Infertility Market Segmentation by Type 2014

Exhibit 18: Global Infertility Market Segmentation by Type 2019

Exhibit 19: Global Infertility Market 2014-2019 (US$ million)

Exhibit 20: Segmentation of Global Infertility Market by Underlying Cause

Exhibit 21: Global Infertility Market by Geographical Segmentation 2014

Exhibit 22: Infertility Market in Americas 2014-2019 (US$ million)

Exhibit 23: Infertility Market in APAC region 2014-2019 (US$ million)

Exhibit 24: Infertility Market in EMEA Region 2014-2019 (US$ million)

Exhibit 25: Global infertility market by region in 2014 and 2019 (US$ million)

Exhibit 26: CooperSurgical: YoY Sales Comparison 2010-2013 (US$ million)

Exhibit 27: Merck's Gonal-f YoY Sales Comparison 2011-2013 (US$ million)

Exhibit 28: Bayer HealthCare: Business Segmentation by Revenue 2013

Exhibit 29: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)

Exhibit 30: Bayer HealthCare: Geographical Segmentation by Revenue 2013

Exhibit 31: CooperSurgical: Business Segmentation 2013

Exhibit 32: CooperSurgical: Business Segmentation by Revenue 2013

Exhibit 33: CooperSurgical: Business Segmentation by Revenue 2012 and 2013 (US$ million)

Exhibit 34: Merck & Co. Inc.: Business Segmentation by Revenue 2013

Exhibit 35: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)

Exhibit 36: Merck & Co. Inc.: Sales by Geography 2013


Enquiry Before Buy